Pharma partner brochure - our portfolio offering at a glance
Discover how we go beyond the essential to support the development of more desirable, safe, and effective therapies.
dsm-firmenich
-
Country/Region:Switzerland
-
On CPHI since:2015
-
Certificates:3
-
Employees:5000+
Other Content from dsm-firmenich (15)
-
News dsm-firmenich launches ModulaSENSE® Bitter – a novel taste modulation technology to enhance drug palatability
dsm-firmenich – a leading innovator in nutrition, health, and beauty – announces the launch of a new technology, ModulaSENSE® Bitter, designed to help pharmaceutical companies improve the taste of drugs and increase patient adherence. This new technology addresses the growing challenge of bitterness in active pharmaceutical ingredients (APIs), helping drug formulators to create more patient-friendly oral medicines. -
Brochure ModulaSENSE Bitter, targeting API bitterness at the recptor level
ModulaSENSE® Bitter combines blockers, maskers and sweeteners to help improve oral dosage palatability and support patient adherence. -
News Transforming Pharma Sustainability: dsm-firmenich’s Nature and Climate Strategy
In the following interview, dsm-firmenich shows how they are leading the way in pharmaceutical sustainability by addressing key challenges, aligning with the UN SDGs, and driving innovative solutions to build resilient supply chains and reduce environmental impact.
-
Brochure Specialty excipients to enhance your drug formulations
Take your drug product to another level with our expertise in vitamins, vitamin derivatives, flavors, sensory and taste solutions curated for pharma. -
News Press Release: dsm-firmenich launches novel taste solutions portfolio for pharmaceutical applications
dsm-firmenich launches taste solutions for pharma, enhancing drug palatability and market readiness with expert-backed flavors, maskers, and sensates. -
News CPHI Frankfurt 2022: Innovator Interview – DSM Biomedical
At CPHI Frankfurt we spoke to Anne-Cecile Bayne, Global Science & Innovation Lead Pharma and Medical Nutrition, and Marc Hendriks, Vice President Strategy & Business Development, on their expertise in nitrosamines and business strategy at DSM Biomedical.
-
Brochure Confidence in sustained release with TheraPEA™
TheraPEA™ is a biodegradable polyester amide platform enabling flexible processing and near-linear drug release over weeks to months. -
Brochure A vitamins API portfolio elevated by Verilege™
Our vitamins API portfolio is elevated by Verilege™, a suite of expert services and superior customer care. -
Whitepaper A comprehensive Taste offering, carefully curated for pharma
Improving the palatability and acceptance of medication to enhance patient compliance and establish clear product differentiation in an increasingly competitive marketplace. -
Brochure dsm-firmenich Pharma Partner Brochure
From high-quality ingredients to regulatory, quality, and sustainability expert services - count on us to help you better the lives of patients worldwide. -
Datasheet An API portfolio elevated by Verilege™
In the world of pharmaceuticals, managing the intricacies of regulatory compliance, ensuring ingredient quality, and meeting sustainability targets is a complex task.
Our API portfolio is elevated by Verilege™, a distinct suite of expert services and superior customer care that helps simplify the drug approval process. Driven by continuous improvement, Verilege™ helps you achieve and uphold regulatory and quality compliance, progress towards your sustainability goals, and de-risk your supply chain. The Verilege™ program comes in tiered service levels that adapt to your individual needs. This allows you to focus on what really matters - bringing life-changing and life-saving medicines to market.